Why the study?
Does multi-vessel revascularisation reduce long-term MACE compared to target-vessel only angioplasty in patients with ST-elevation myocardial infarction?
Does multi-vessel revascularisation reduce long-term MACE compared to target-vessel only angioplasty in patients with ST-elevation myocardial infarction?
In patients with STEMI, multivessel revascularization (whether staged or simultaneous) reduces long-term major adverse cardiac events compared to culprit-vessel only angioplasty.
Supports multivessel revascularization over culprit-only PCI in STEMI to reduce long-term MACE; confirms equivalence of staged and simultaneous approaches.
Culprit vessel-only angioplasty was associated with the highest rate of long-term MACE compared with multivessel treatment. Patients scheduled for staged revascularisation experienced a similar rate of MACE to patients undergoing complete simultaneous treatment of non-IRA.
No takes yet. Share an insight, caveat, or question.
Politi et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Heart